zenas_tech_cardiac

 

news_callout
news_services
news_contact_us
news_callout

Zenas Technologies Will Head to Society of Toxicology Annual Meeting in March

New Orleans, Louisiana (January 2012) – Zenas Technologies will be exhibiting at the Society of Toxicology 51st Annual Meeting in San Francisco March 11-15.

“Zenas Technologies attended SOT last year and we found it an ideal venue for clearly communicating our cardiac and CNS ion channel services and assays,” says Brent Kovach, Zenas Business Development Director.

Zenas Technologies will also be unveiling several new assays adding to the company’s comprehensive cardiovascular and central nervous system capabilities. Continue Reading

________________________________________________________

Zenas Technologies Exhibiting at ACT Annual Meeting in November

New Orleans, Louisiana (October 2011)– Zenas Technologies will be in Phoenix at the 32nd American College of Toxicology meeting, in booth 154, November 6th through the 9th.

“We welcome the opportunity to share more information about our cardiac ion channel and CNS assays,” says Dr. William Crumb, Zenas Founder and Scientific Director. “I look forward to explaining how we leverage the scientific advantages of our comprehensive assays, from utilizing native human cardiac myocytes at physiologic temperatures to screening compounds against neuronal ion channels in our CNS screenings.”
Continue Reading

________________________________________________________


Zenas Technologies to Present Abstract at Safety Pharmacology Society Annual Meeting

Metairie, Louisiana (August 2011)– Zenas Techonolgies will present an abstract at the Safety Pharmacology Society Annual Meeting in Innsbruck, Austria September 19th through the 22nd.

The Zenas abstract builds on the premise that a hERG dataset obtained under appropriate experimental conditions can be used to predict and quantify drug-associated changes in QTc in patients.
Continue Reading

________________________________________________________


Zenas Technologies to Exhibit at Safety Pharmacology Society Annual Meeting

Metairie, Louisiana (May 2011) – For the first time, Zenas Techonolgies will be attending the Safety Pharmacology Society Annual Meeting. Dr. William Crumb, Zenas Founder and Scientific Director, and Brent Kovach, Zenas Business Development Director, will head to Innsbruck, Austria for the conference to be held on September 19th through the 22nd.
Continue Reading

________________________________________________________


Dr. William Crumb Joins CorDynamics Corporate
Advisory Team

Chicago, Illinois/Metairie, Louisiana (February 2011) – Dr. William Crumb, founder and scientific director of Zenas Technologies, will be lending his cardiac ion channel expertise to the CorDynamics Corporate Advisory Team.

“Collaborating with CorDynamics on their cardiovascular projects and what we’ve perfected at Zenas Technologies will be a natural fit for both of our companies,” says Dr. Crumb.
Continue Reading